Eppendorf Licenses Thermal Gradient IP to Takara Bio | GenomeWeb

Eppendorf said this week that it has licensed patents covering gradient technology for thermal cyclers to Takara Bio.

The licensed patents include US Nos. 6,767,512 and 7,074,367, which cover thermal gradient block technology that Eppendorf uses in its Mastercycler Pro Gradient, Mastercycler Gradient, and Mastercycler EP RealPlex thermal cyclers.

The thermal gradient block technology describes a thermostated block that is in contact with wells containing sample vials and generates different temperatures at different sites of the block.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.

Mar
02
Sponsored by
VelaDx

This online seminar will highlight recent advances in the use of next-generation sequencing to detect drug-resistant mutations in patients with HIV or HCV.